ST. LOUIS, MO (July 15, 2013) – RiverVest Venture Partners announced today that Abbott Laboratories is acquiring RiverVest medical device portfolio company IDEV Technologies for $310 million.
Cleveland, OH (July 9, 2013) – In 2012, 108 Northeast Ohio companies raised $212 million in equity capital from angel and venture capitalists to grow their businesses. Still, the process of raising capital is a struggle for many, if not most, entrepreneurs. Imagine convincing potential investors—especially ones you don’t know—to put money into your company above other opportunities. It requires, among other things, technique, a strong business model and confidence.
JumpStart’s Samantha Fryberger sat down with a succesful fundraiser (OnShift CEO Mark Woodka) and an investor (Karen Spilizewski of Rivervest Venture Partners) to find out what else it takes to get the money your company needs to grow.
Listen to the conversation here.
ST. LOUIS (May 13, 2013) – RiverVest Venture Partners announced today that Bradley Keller, Ph.D. has joined the life sciences venture capital firm as an Entrepreneur-in-Residence.
ST. LOUIS (March 26, 2013) – RiverVest Venture Partners’ Principal Niall O’Donnell, Ph.D., has been invited to serve on the Experts Panel at Stevenage Bioscience Catalyst, the U.K.’s first open innovation bioscience campus focused on driving early-stage biotech, pharma and medtech developments.
SAN DIEGO, March 20, 2013 /PRNewswire-USNewswire/ — The Rady School of Management’s student-run venture capital fund, the Rady Venture Fund, has participated in a $16 million Series B raise in startup Savara Pharmaceuticals, which is developing an inhalable antibiotic to treat cystic fibrosis patients with lung infections.
Aug. 24, 2012 – CLEVELAND – Rivervest’s Karen Spilizewski is scheduled to join other entrepreneurial luminaries when she speaks at the 2012 National Association for Seed and Venture Funds (NASVF) Conference. Keynote speakers include Steve Case, TechStars’ Katie Rae and Open Table’s Chuck Templeton, who are all scheduled to address this year’s theme: “Advancing Innovation: Seeding Tomorrow’s Opportunities.”
Once a major headquarters town, the Gateway City is becoming more entrepreneurial….Read More
May 5, 2012 – William A. Peck, MD, the Alan A. and Edith L. Wolff Distinguished Professor of Medicine and director of the Center for Health Policy at Washington University in St. Louis, was presented with the Washington University Eliot Society “Search” Award at the 45th annual dinner of the William Greenleaf Eliot Society May 1 at the Ritz-Carlton Hotel in Clayton, Mo. Read more
March 16, 2012 – A $1 billion-plus deal between Boston Scientific Corp. and medical device firm Cameron Health Inc. is bringing a payout of more than $12 million to RiverVest Venture Partners and its investors. Read More
March 8, 2012 – ST. LOUIS, MO & CLEVELAND, OH – RiverVest Venture Partners today announced that RiverVest V.P. Karen Spilizewski will speak at BioMEMS 2012’s Venture Capital session on March 22.
The conference will focus on MEMS technologies for biomedical applications, or BioMEMS, whose market size is estimated at $1.7 billion. BioMEMS, or the biological and biomedical applications of micro- and nanotechnology, is finding widespread applicability and uses in areas such as diagnostics, therapeutics and tissue engineering.